| Product Code: ETC7733091 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Blockbuster Oncology Brands Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Blockbuster Oncology Brands Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Blockbuster Oncology Brands Market - Industry Life Cycle |
3.4 Japan Blockbuster Oncology Brands Market - Porter's Five Forces |
3.5 Japan Blockbuster Oncology Brands Market Revenues & Volume Share, By Brands, 2021 & 2031F |
3.6 Japan Blockbuster Oncology Brands Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Japan Blockbuster Oncology Brands Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Japan |
4.2.2 Technological advancements in oncology treatments |
4.2.3 Growing investments in research and development for oncology drugs |
4.3 Market Restraints |
4.3.1 Stringent regulatory approvals for oncology drugs in Japan |
4.3.2 High cost of oncology treatments |
4.3.3 Competition from generic drug manufacturers |
5 Japan Blockbuster Oncology Brands Market Trends |
6 Japan Blockbuster Oncology Brands Market, By Types |
6.1 Japan Blockbuster Oncology Brands Market, By Brands |
6.1.1 Overview and Analysis |
6.1.2 Japan Blockbuster Oncology Brands Market Revenues & Volume, By Brands, 2021- 2031F |
6.1.3 Japan Blockbuster Oncology Brands Market Revenues & Volume, By Opdivo, 2021- 2031F |
6.1.4 Japan Blockbuster Oncology Brands Market Revenues & Volume, By Keytruda, 2021- 2031F |
6.1.5 Japan Blockbuster Oncology Brands Market Revenues & Volume, By Perjeta, 2021- 2031F |
6.1.6 Japan Blockbuster Oncology Brands Market Revenues & Volume, By Ibrance, 2021- 2031F |
6.1.7 Japan Blockbuster Oncology Brands Market Revenues & Volume, By Tecentriq, 2021- 2031F |
6.1.8 Japan Blockbuster Oncology Brands Market Revenues & Volume, By Gazyva, 2021- 2031F |
6.1.9 Japan Blockbuster Oncology Brands Market Revenues & Volume, By Darzalex, 2021- 2031F |
6.1.10 Japan Blockbuster Oncology Brands Market Revenues & Volume, By Darzalex, 2021- 2031F |
6.2 Japan Blockbuster Oncology Brands Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Japan Blockbuster Oncology Brands Market Revenues & Volume, By Lung cancer, 2021- 2031F |
6.2.3 Japan Blockbuster Oncology Brands Market Revenues & Volume, By Breast cancer, 2021- 2031F |
6.2.4 Japan Blockbuster Oncology Brands Market Revenues & Volume, By Multiple myeloma, 2021- 2031F |
6.2.5 Japan Blockbuster Oncology Brands Market Revenues & Volume, By Lymphoma, 2021- 2031F |
6.2.6 Japan Blockbuster Oncology Brands Market Revenues & Volume, By Others, 2021- 2031F |
7 Japan Blockbuster Oncology Brands Market Import-Export Trade Statistics |
7.1 Japan Blockbuster Oncology Brands Market Export to Major Countries |
7.2 Japan Blockbuster Oncology Brands Market Imports from Major Countries |
8 Japan Blockbuster Oncology Brands Market Key Performance Indicators |
8.1 Number of clinical trials for oncology drugs in Japan |
8.2 Adoption rate of innovative oncology treatments in Japan |
8.3 Rate of approval for new oncology drugs in the Japanese market |
9 Japan Blockbuster Oncology Brands Market - Opportunity Assessment |
9.1 Japan Blockbuster Oncology Brands Market Opportunity Assessment, By Brands, 2021 & 2031F |
9.2 Japan Blockbuster Oncology Brands Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Japan Blockbuster Oncology Brands Market - Competitive Landscape |
10.1 Japan Blockbuster Oncology Brands Market Revenue Share, By Companies, 2024 |
10.2 Japan Blockbuster Oncology Brands Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here